Sensei Biotherapeutics Statistics
Total Valuation
SNSE has a market cap or net worth of $17.45 million. The enterprise value is -$184.31 million.
| Market Cap | 17.45M |
| Enterprise Value | -184.31M |
Important Dates
The next estimated earnings date is Tuesday, August 4, 2026, before market open.
| Earnings Date | Aug 4, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SNSE has 1.34 million shares outstanding. The number of shares has increased by 0.96% in one year.
| Current Share Class | 1.34M |
| Shares Outstanding | 1.34M |
| Shares Change (YoY) | +0.96% |
| Shares Change (QoQ) | +2.67% |
| Owned by Insiders (%) | 11.25% |
| Owned by Institutions (%) | 47.68% |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 14.39
| Current Ratio | 14.39 |
| Quick Ratio | 14.29 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -5,801.28 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -95.24% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -97.10% |
| Weighted Average Cost of Capital (WACC) | 2.95% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$6.36M |
| Employee Count | 29 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +98.84% in the last 52 weeks. The beta is -0.23, so SNSE's price volatility has been lower than the market average.
| Beta (5Y) | -0.23 |
| 52-Week Price Change | +98.84% |
| 50-Day Moving Average | 23.38 |
| 200-Day Moving Average | 16.25 |
| Relative Strength Index (RSI) | 35.60 |
| Average Volume (20 Days) | 46,883 |
Short Selling Information
The latest short interest is 798,278, so 59.49% of the outstanding shares have been sold short.
| Short Interest | 798,278 |
| Short Previous Month | 815,539 |
| Short % of Shares Out | 59.49% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 23.85 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -185.64M |
| Pretax Income | -184.46M |
| Net Income | -184.46M |
| EBITDA | -185.51M |
| EBIT | -185.64M |
| Earnings Per Share (EPS) | -$145.28 |
Balance Sheet
The company has $202.79 million in cash and $1.04 million in debt, with a net cash position of $201.75 million or $150.34 per share.
| Cash & Cash Equivalents | 202.79M |
| Total Debt | 1.04M |
| Net Cash | 201.75M |
| Net Cash Per Share | $150.34 |
| Equity (Book Value) | -137.29M |
| Book Value Per Share | -102.43 |
| Working Capital | 190.04M |
Cash Flow
In the last 12 months, operating cash flow was -$24.09 million and capital expenditures -$22,000, giving a free cash flow of -$24.11 million.
| Operating Cash Flow | -24.09M |
| Capital Expenditures | -22,000 |
| Depreciation & Amortization | 135,000 |
| Net Borrowing | -641,000 |
| Free Cash Flow | -24.11M |
| FCF Per Share | -$17.97 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
SNSE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.96% |
| Shareholder Yield | n/a |
| Earnings Yield | -1,057.35% |
| FCF Yield | -138.23% |
Analyst Forecast
The average price target for SNSE is $52.50, which is 303.85% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $52.50 |
| Price Target Difference | 303.85% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 17, 2025. It was a reverse split with a ratio of 1:20.
| Last Split Date | Jun 17, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:20 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |